Swiss National Bank lowered its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) by 1.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 193,500 shares of the company’s stock after selling 2,900 shares during the quarter. Swiss National Bank owned about 0.23% of Pediatrix Medical Group worth $2,875,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also modified their holdings of the business. Eagle Bay Advisors LLC grew its stake in Pediatrix Medical Group by 122.5% in the 2nd quarter. Eagle Bay Advisors LLC now owns 1,595 shares of the company’s stock valued at $34,000 after buying an additional 878 shares during the last quarter. Royal Bank of Canada grew its stake in Pediatrix Medical Group by 97.3% in the 3rd quarter. Royal Bank of Canada now owns 2,166 shares of the company’s stock valued at $35,000 after buying an additional 1,068 shares during the last quarter. Point72 Hong Kong Ltd acquired a new position in Pediatrix Medical Group in the 3rd quarter valued at $43,000. Marshall & Sullivan Inc. WA acquired a new position in Pediatrix Medical Group in the 4th quarter valued at $43,000. Finally, Tower Research Capital LLC TRC grew its stake in Pediatrix Medical Group by 123.1% in the 3rd quarter. Tower Research Capital LLC TRC now owns 6,558 shares of the company’s stock valued at $108,000 after buying an additional 3,618 shares during the last quarter. Institutional investors own 95.99% of the company’s stock.
Insider Activity at Pediatrix Medical Group
In related news, Director Shirley A. Weis sold 17,993 shares of Pediatrix Medical Group stock in a transaction dated Thursday, May 18th. The shares were sold at an average price of $13.55, for a total transaction of $243,805.15. Following the completion of the transaction, the director now directly owns 18,675 shares of the company’s stock, valued at approximately $253,046.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.00% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Pediatrix Medical Group Price Performance
Shares of Pediatrix Medical Group stock opened at $13.53 on Wednesday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.44 and a current ratio of 1.44. The firm’s 50-day simple moving average is $14.27 and its 200-day simple moving average is $15.01. Pediatrix Medical Group, Inc. has a twelve month low of $12.84 and a twelve month high of $23.95. The firm has a market cap of $1.13 billion, a P/E ratio of 11.09, a price-to-earnings-growth ratio of 0.61 and a beta of 1.74.
Pediatrix Medical Group Profile
Pediatrix Medical Group, Inc engages in the provision of physician services. It includes newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.
- Get a free copy of the StockNews.com research report on Pediatrix Medical Group (MD)
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.